会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 5. 发明授权
    • Beta-lactamase inhibitor prodrug
    • β-内酰胺酶抑制剂前药
    • US07091197B2
    • 2006-08-15
    • US10648408
    • 2003-08-25
    • Anthony MarfatDale G. McLeod
    • Anthony MarfatDale G. McLeod
    • C07D499/861A61K31/43A61P31/04
    • C07D499/00
    • Prodrugs of 6-β-hydroxymethylpenicillanic acid sulfone having the structure wherein R is H or methyl, and solvates thereof, are disclosed. Also disclosed are pharmaceutical compositions comprising a prodrug of the present invention or a solvate thereof, an optional beta-lactam antibiotic and a pharmaceutically acceptable excipient. Further disclosed is a method for increasing the therapeutic effectiveness of a beta-lactam antibiotic in a mammal by administering an effective amount of a beta-lactam antibiotic and an effectiveness-increasing amount of a prodrug of the present invention, or a solvate thereof.Additionally disclosed is a method for treating a bacterial infection in a mammal by administering a therapeutically effective amount of a pharmaceutical composition of the present invention to a mammal in need thereof.
    • 公开了具有其中R为H或甲基的结构及其溶剂合物的6-β-羟甲基青霉烷酸砜的前药。 还公开了包含本发明的前药或其溶剂合物,任选的β-内酰胺抗生素和药学上可接受的赋形剂的药物组合物。 进一步公开的是通过施用有效量的β-内酰胺抗生素和增加有效量的本发明的前药或其溶剂化物来增加哺乳动物中β-内酰胺抗生素的治疗有效性的方法。 另外公开了通过向有需要的哺乳动物施用治疗有效量的本发明药物组合物来治疗哺乳动物细菌感染的方法。